Key Insights

Highlights

Treatment Research

20 treatments under study, led by Loratadinratiopharm 10 Mg Tabletten

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
SYF919fa44e73e34c9bb074caf915dde75bPhase 3Unknown

A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescents and adults with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.

Showing all 1 trials

Research Network

Common Treatments

  • Loratadinratiopharm 10 Mg Tabletten1
  • Rupatadin Al 10 Mg Tabletten1
  • Allegra Allergietabletten20 Mg Tabletten1
  • Alk Prick Positiv Kontrolle Lösung Für Hautpricktest1
  • Alvesco 160 Mikrogramm Druckgasinhalation Lösung1

Active Sponsors

  • Inmunotek S.L.1

Activity Timeline